Topic: Price fixing

Texas judge rejects water agency’s state-action immunity claims

A federal judge in Houston has ruled that a Texas water agency must face two private utility companies’ claims that it monopolised the raw water supply in a northern suburb of that city.

18 August 2020

South African enforcer loses cement cartel appeal

Attending a meeting where price-fixing or market allocation agreements are made does not automatically prove a company is guilty of participating in a cartel, an appellate court in South Africa has ruled.

14 August 2020

South Africa’s 13-year maize cartel probe nears conclusion

South Africa’s antitrust watchdog is nearing the end of its “protracted and complex” maize milling cartel investigation – which began in 2007 – after the country’s competition tribunal confirmed its 14th and penultimate settlement agreement.

11 August 2020

Owing to coronavirus, CCI adopts “lenient” approach in admitted cartel cases

Competition authorities around the world have adopted measures to help businesses collaborate throughout the covid-19 pandemic, although they have warned against taking advantage of the health crisis. Khaitan & Co partner Sagardeep Rathi and senior associate Radhika Seth examine two recent decisions by the Competition Commission of India not to issue fines in admitted cartel cases, and what that means for cartel deterrence.

06 August 2020

New Zealand enforcer forgoes cartel fine due to coronavirus

A horse transportation company has escaped fines for price fixing in New Zealand, because of the impact of the covid-19 pandemic.

29 July 2020

Aluminium warehouse plaintiffs denied class cert

Plaintiffs alleging that Goldman Sachs, JPMorgan and Glencore conspired to manipulate prices of aluminium cannot establish they suffered common antitrust injury, a New York federal court has ruled in denying class certification.

27 July 2020

Taro admits collusion to end DOJ probe

Taro Pharmaceuticals has entered into a deferred prosecution agreement with the Antitrust Division, but it is costing the generic drugmaker $419 million and an admission that its price-fixing conspiracy impacted more than $500 million worth of commerce.

24 July 2020

Generic pharma plaintiffs say states’ Teva case should be among first tried

Drug purchasers suing generic pharmaceutical companies for an alleged antitrust conspiracy have told a federal judge that the case brought by a large group of state attorneys general centred on Teva Pharmaceuticals should be among the first to go to trial.

10 July 2020

UK court sides with CMA in first contested disqualification case

A UK court has disqualified a former estate agent director for failing to prevent a price-fixing conspiracy, in the first contested case of its kind.

03 July 2020

CMA settles with eye treatment cartelists

The UK’s Competitions and Markets Authority has fined a private hospital group and seven consultants £1.2 million, as they admitted to fixing prices for private eyecare appointments.

01 July 2020

Get unlimited access to all Global Competition Review content